Decline in Investment Securities Prices and Poor Performance by Investees
First written in FY2016. 15 of 24 entries say "Mitigated", first in FY2021-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2019: 42 of 80 companies on the "Worse" side.
24 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「Other securities 204,852 60,223 144,628」
The unrealized gain on other securities increased from ¥96.723 million in the previous fiscal year to ¥144.628 million, expanding the positive unrealized gain. - 2026-05-14MitigatedResults
「その他有価証券評価差額金 66,284 99,114」
その他有価証券評価差額金は前年度末の66,284千円から99,114千円へ増加し、評価面の影響は改善方向となった。 - FY2026-H1MitigatedAnnual report
「Net unrealized gains on other securities 66,284 82,744」
Net unrealized gains on other securities increased from ¥66.284 million at the end of the previous consolidated fiscal year to ¥82.744 million, indicating an improvement in valuation effects. - FY2025Decrease in unrealized gains on other securitiesAnnual report
「Net unrealized gains on other securities 77,215 66,284」
Net unrealized gains on other securities decreased from ¥77.215 million at the end of the previous fiscal year to ¥66.284 million, but the positive unrealized gain was maintained. - FY2025-H1Decrease in unrealized gains on other securitiesAnnual report
「Net unrealized gains on other securities 77,215 51,651」
Net unrealized gains on other securities decreased from ¥77.215 million at the end of the previous consolidated fiscal year to ¥51.651 million, but the positive unrealized gain was maintained. - FY2024MitigatedAnnual report
「Net unrealized gains on other securities 44,100 77,215」
Net unrealized gains on other securities increased from ¥44.100 million at the end of the previous fiscal year to ¥77.215 million, indicating an improvement in valuation effects. Although the risk is quantified, this does not state that an impairment loss occurred during the fiscal year. - FY2024-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities 44,100 50,891」
The valuation difference on available-for-sale securities increased from ¥44.100 million at the end of the previous consolidated fiscal year to ¥50.891 million, improving the valuation impact. - FY2024-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities 44,100 50,426」
The valuation difference on available-for-sale securities increased from ¥44.100 million at the end of the previous consolidated fiscal year to ¥50.426 million at the end of the current first quarter, improving the valuation impact. - FY2023-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities 22,896 30,571」
The valuation difference on available-for-sale securities increased from ¥22.896 million at the end of the previous consolidated fiscal year to ¥30.571 million, improving the valuation impact. - FY2023-Q2Update to valuation difference on available-for-sale securitiesAnnual report
「Valuation difference on available-for-sale securities 22,896 22,098」
The valuation difference on available-for-sale securities was updated from ¥22.896 million at the end of the previous consolidated fiscal year to ¥22.098 million. - FY2023-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities 22,896 24,495」
The valuation difference on available-for-sale securities increased from ¥22.896 million at the end of the previous consolidated fiscal year to ¥24.495 million, improving the valuation impact. - FY2022MitigatedAnnual report
「Total 88,040 55,058 32,981」
The valuation difference on available-for-sale securities increased from a positive ¥7.569 million in the previous fiscal year to a positive ¥32.981 million, improving the valuation impact. - FY2022-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities 5,254 20,694」
The valuation difference on available-for-sale securities increased from ¥5.254 million at the end of the previous consolidated fiscal year to ¥20.694 million, improving the valuation impact. - FY2022-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities 5,254 15,048」
The valuation difference on available-for-sale securities increased from ¥5.254 million at the end of the previous consolidated fiscal year to ¥15.048 million, improving the valuation impact. - FY2022-Q1MitigatedAnnual report
「Valuation difference on available-for-sale securities 5,254 14,210」
The valuation difference on available-for-sale securities increased from ¥5.254 million at the end of the previous consolidated fiscal year to ¥14.210 million, improving the valuation impact. - FY2021MitigatedAnnual report
「Total 61,682 54,112 7,569」
The valuation difference on available-for-sale securities changed from a negative ¥10.106 million in the previous fiscal year to a positive ¥7.569 million in the current fiscal year, improving the valuation impact. - FY2021-Q3MitigatedAnnual report
「Valuation difference on available-for-sale securities − 7,015 − 369」
The deficit in the valuation difference on available-for-sale securities narrowed from ¥7.015 million at the end of the previous consolidated fiscal year to ¥369 thousand, improving the valuation impact. - FY2021-Q2MitigatedAnnual report
「Valuation difference on available-for-sale securities − 7,015 − 2,265」
The deficit in the valuation difference on available-for-sale securities narrowed from ¥7.015 million at the end of the previous consolidated fiscal year to ¥2.265 million, improving the valuation impact. - FY2020MaterialisedAnnual report
「Total 43,203 53,310 −10,106」
The valuation difference on investment securities changed from a positive amount in the previous fiscal year to a negative ¥10.106 million in the current fiscal year, with the impact of declines in share prices and other factors reflected in results on a valuation basis. - FY2019RestatedAnnual report
「If valuation losses arise due to a decline in share prices or poor performance by investees, the results of operations and financial position of the group may be affected.」
The risks of declines in investment securities prices and poor performance by investees continue to be disclosed. - FY2019-Q3RestatedAnnual report
「During the cumulative third quarter of the fiscal year, there were no newly arising business or other risks. In addition, there were no material changes to the business or other risks described in the securities report for the previous fiscal year.」
It has been determined that there have been no material changes to the risks related to declines in investment securities prices and poor performance by investees. - FY2018RestatedAnnual report
「If valuation losses arise due to a decline in share prices or poor performance by investees, the results of operations and financial position of the group may be affected.」
The risks of declines in investment securities prices and poor performance by investees continue to be disclosed. - FY2017RestatedAnnual report
「If valuation losses arise due to a decline in share prices or poor performance by investees, the results of operations and financial position of the group may be affected.」
The risks of declines in investment securities prices and poor performance by investees have been reiterated. - FY2016First statedAnnual report
「If valuation losses arise due to a decline in share prices or poor performance by investees, the results of operations and financial position of the group may be affected.」
Risks related to the market prices of held investment securities and the performance of investees.